Compagnon depuis 2017

Dr. Thomas Aloia is a Hepatobiliary Surgical Oncologist in the Gastrointestinal Center at the University of Texas MD Anderson Cancer Center.


Dr. Aloia received his medical degree from the University of California – Los Angeles Geffen School of Medicine. His postgraduate training included a general and thoracic surgery residency at Duke University Medical Center and fellowships in Surgical Oncology at MD Anderson and Hepatobiliary Surgery/Liver Transplantation at the Paul Brousse Hospital in Paris, France. He has received a Certificate in Healthcare Management from Rice University Jones Business School and Master’s Degree in Health Care Management from the Harvard T.H. Chan School of Public Health.


Dr. Aloia’s clinical expertise is in hepatobiliary surgery, gastrointestinal surgical oncology, minimally invasive surgery and liver transplantation surgery. He has published over 250 peer- reviewed manuscripts in the focus areas of surgical outcomes, GI oncology, enhanced recovery and value-based healthcare. He serves as an ad hoc reviewer for multiple medical and surgical journals and is on the editorial board of The Journal of Oncology Practice, Annals of Surgery and the Annals of Surgical Oncology.


Having served multiple administrative roles in the areas of patient safety, quality, and outcomes, he is currently MD Anderson’s Chief Quality Officer and Head of the Institute of Cancer Care Innovation.




Twitter: @mdahpbaloia